Consensus Illumina, Inc.

Equities

ILMN

US4523271090

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-16 pm EDT			5-day change	1st Jan Change
117.7 ^USD	-2.86%		-11.89%	-15.48%

11:31am	ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca
11:17am	Baptista Research Downgrades Illumina to Hold From Buy, Adjusts PT to $149.60 From $145	MT

Evolution of the average Target Price on Illumina, Inc.

Price target over the last 5 years

History of analyst recommendation changes

ecff4b8353d13578.b6Q-YFcETh8roJlZTZ3bGQilH6CAdOolbDQNK-geOGc.P-JTN2RrPk97zKo2fsSNfW7UKuXxId5qNgBcaL5uThI13UZQMXE3W1vDrQ~0fcf4fe66b7cc21f8f70db001860a853

Analyst Recommendations on Illumina, Inc.

ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca	05:31am
Baptista Research Downgrades Illumina to Hold From Buy, Adjusts PT to $149.60 From $145	05:17am	MT
Leerink Partners Adjusts Illumina's Price Target to $155 From $170	Apr. 12	MT
RBC Cuts Price Target on Illumina to $253 From $258, Keeps Outperform Rating	Apr. 08	MT
OTR Global Downgrades Illumina to Mixed From Positive	Mar. 20	MT
Exclusive-Icahn drops Illumina board challenge threat, sources say	Mar. 12	RE
UBS Adjusts Illumina Price Target to $145 From $111, Maintains Neutral Rating	Feb. 09	MT
TD Cowen Adjusts Price Target on Illumina to $150 From $144, Maintains Market Perform Rating	Feb. 09	MT
This time it's for real	Feb. 09
Barclays Adjusts Price Target on Illumina to $85 From $80, Maintains Underweight Rating	Feb. 09	MT
Citigroup Adjusts Price Target on Illumina to $145 From $120, Maintains Neutral Rating	Feb. 09	MT
Stifel Adjusts Price Target on Illumina to $160 From $125, Maintains Buy Rating	Feb. 09	MT
Baird Adjusts Price Target on Illumina to $146 From $144, Maintains Neutral Rating	Feb. 09	MT
ANALYST RECOMMENDATIONS : Lululemon, Nvidia, PayPal, Spotify, Uber...	Feb. 09
ANALYST RECOMMENDATIONS : Dollar Tree, Intel, Snap, Hershey, Fresnillo...	Jan. 29
Barclays Adjusts Price Target on Illumina to $80 From $50, Maintains Underweight Rating	Jan. 25	MT
ANALYST RECOMMENDATIONS : Burberry Group, Blackrock, JPMorgan Chase, Qualcomm, Sage...	Jan. 15
TD Cowen Downgrades Illumina to Market Perform From Outperform	Jan. 04	MT
RBC Trims Price Target on Illumina to $258 From $260 Amid Grail Divestment Plan, Keeps Outperform Rating	Dec. 19	MT
Scotiabank Upgrades Illumina to Sector Outperform From Sector Perform, Cuts Price Target to $185 From $205	Dec. 18	MT
ANALYST RECOMMENDATIONS : Abbvie, Blackrock, Chubb, JPMorgan, Salesforce...	Dec. 18
ANALYST RECOMMENDATIONS : Adobe, Blackrock, Roblox, Snap, US Bancorp...	Dec. 15
Stephens Initiates Illumina With Overweight Rating, Price Target is $170	Dec. 14	MT
BofA Securities Downgrades Illumina to Underperform From Neutral, Price Target to $100	Dec. 12	MT
ANALYST RECOMMENDATIONS : Adobe, AMD, Apple, Costco, HP, Snap...	Dec. 11

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

121.2 USD

Average target price

160.7 USD

Spread / Average Target

+32.61%

High Price Target

253 USD

Spread / Highest target

+108.81%

Low Price Target

100 USD

Spread / Lowest Target

-17.46%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Illumina, Inc.

Leerink Partners
RBC Capital Markets
OTR Global
UBS
TD Cowen
Barclays
Citigroup
Stifel Nicolaus
Baird
Scotiabank
Stephens Inc.
BofA Securities
Canaccord Genuity
Bernstein
Piper Sandler
HSBC
JPMorgan Chase
Evercore ISI
Credit Suisse
SVB Securities LLC
Argus
Morgan Stanley
Cowen
SVB Leerink
BTIG
Wells Fargo Securities
Atlantic Equities

Ratings for Illumina, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar